o/s now at 330 mil,doubled from the last 10q....
Item 5. Interest in Securities of the Issuer
Item 5 of the Schedule 13D and is hereby amended to add the following:
(a, b) The aggregate number of shares of Common Stock and the percentage of total outstanding Common Stock beneficially owned by the Reporting Persons as of October 19, 2012 is set forth below:
Reporting Person
Number of Shares of
Common Stock
Beneficially Owned1, 2
Percentage of
Outstanding Shares of
Common Stock2
Number of
Outstanding Shares of
Common Stock3
Wanxiang Group
16,486,308
4.99%
330,386,918
Wanxiang America
16,486,308
4.99%
330,386,918
Wanxiang Foundation
16,486,308
4.99%
330,386,918
Guanqiu Foundation
16,486,308
4.99%
330,386,918
Dr. Lu
16,486,308
4.99%
330,386,918
1 The beneficial ownership for which each figure is provided in this column is the shared, not sole, power to vote or to direct the vote, and the shared, not sole, power to dispose or to direct the disposition of the Common Stock.
2 Pursuant to the Waiver Letter (defined in Item 6 of this Schedule), Bridge Warrant No. W1 cannot be exercised to the extent Wanxiang and its affiliates would beneficially own in excess of 4.99% of the Common Stock.
3 This figure is based upon information provided by the Issuer on October 1, 2012, indicating that, as of October 1, 2012, there were 313,900,610 shares of Common Stock outstanding. Based on that information, as of October 19, 2012, each of the Reporting Persons may be deemed the beneficial owner of 16,486,308 shares of Common Stock upon conversion of each of Bridge Warrant No. W1. Pursuant to Rule 13d-3(d)(1)(i)(D), such Common Stock has been added to the Issuer's Common Stock outstanding, for a total of 330,386,918 shares of Common Stock outstanding.
News 
Market Data 
Discover 
AI
